Table 1 Baseline characteristics of study population in development Cohort.
Variables | Non-TIC Group n = 898 | TIC Group n = 306 | P value | ||
|---|---|---|---|---|---|
Demographic | |||||
Sex | Male | 232(25.8%) | 82(26.8%) | 0.741 | |
Age | 51(39–59) | 52(37–65) | 0.089 | ||
Preoperative comorbidities | |||||
Hypertension | 89(9.9%) | 33(10.8%) | 0.662 | ||
Coronary Heart Disease | 7(0.8%) | 3(1.0%) | 0.721 | ||
Diabetes | 35(3.9%) | 21(6.9%) | 0.033 | ||
Cerebrovascular Disease | 9(1.0%) | 2(0.2%) | 0.739 | ||
COPD | 13(1.4%) | 4(1.3%) | 1 | ||
CKD | 2(0.2%) | 1(0.3%) | 1 | ||
Injury situation | |||||
Mechanism of Injury | 0.027 | ||||
Traffic accidents | 475(39.4%) | 173(56.5%) | |||
Drop from height | 244(27.2%) | 65(21.2%) | |||
fall | 70(7.8%) | 37(12.1%) | |||
Sharp instrumental injury | 33(3.7%) | 10(3.3%) | |||
Others | 77(8.6%) | 20(6.5%) | |||
Location of Injury | 0.027 | ||||
Head and Neck | 475(39.4%) | 173(56.5%) | |||
Face | 244(27.2%) | 65(21.2%) | |||
Chest | 70(7.8%) | 37(12.1%) | |||
Abdominal | 33(3.7%) | 10(3.3%) | |||
Limbs and Pelvis | 77(8.6%) | 20(6.5%) | |||
Appearance | |||||
Multiple injuries | 688(76.6%) | 219(71.6%) | |||
Preoperative situation | |||||
Shock | 150(16.7%) | 127(41.5%) | < 0.001 | ||
Emergency | 472(52.6%) | 248(81.1%) | < 0.001 | ||
ASA Classification | < 0.001 | ||||
I | 2(0.2%) | 0(0.0%) | |||
II | 354(39.4%) | 73(23.9%) | |||
III | 430(47.9%) | 136(44.4%) | |||
IV | 100(11.1%) | 76(24.8%) | |||
V | 12(1.3%) | 21(6.9%) | |||
ISS score | 18.5(17–22) | 21(17–27) | < 0.001 | ||
Systolic Blood Pressure (mmHg) | 122(108–137) | 122.5(98.3–142) | 0.903 | ||
Diastolic Blood Pressure (mmHg) | 77(67–85) | 74.5(62–86) | 0.193 | ||
Heart rate (BPM) | 86(78–101) | 90(78–114) | < 0.001 | ||
Preoperative intervention | |||||
Interventional Procedure | 37(4.1%) | 12(3.9%) | 0.879 | ||
Blood transfusion | 75(8.4%) | 21(6.9%) | 0.406 | ||
Haemostatic drugs | 539(60.0%) | 133(43.5%) | < 0.001 | ||
Tracheal Intubation | 60(6.7%) | 65(21.2%) | < 0.001 | ||
Vasoperssor | 447(49.8%) | 261(85.3%) | < 0.001 | ||
Preoperative laboratory tests | |||||
WBC (109/L) | 11.2(7.87–16.04) | 14.9(10.06–19.67) | < 0.001 | ||
RBC (1012/L) | 3.71(3.17–4.28) | 3.66(3.13–4.23) | 0.385 | ||
HGB (g/L) | 113(95–132) | 111(95-129.5) | 0.199 | ||
HCT (%) | 34.6(29.3–39.5) | 33.5(28.9–38.7) | 0.191 | ||
PLT (109/L) | 199(149–259) | 182.5(134–227) | < 0.001 | ||
Neu% (%) | 83.7(77.4–88.9) | 85.4(80.7–89.7) | 0.012 | ||
Neu (109/L) | 9.42(6.12–14.2) | 12.64(8.10-17.51) | < 0.001 | ||
RDW (%) | 12.7(12.3–13.4) | 12.9(12.3–13.8) | 0.005 | ||
PDW (%) | 16.2(16.0-16.5) | 16.3(16-16.5) | 0.116 | ||
MPV (fL) | 10.1(9.2–11.1) | 10.2(9.3–11.4) | 0.022 | ||
Cr (umol/L) | 6.1(4.8–7.4) | 6.6(5.1–7.4) | < 0.001 | ||
Urea (umol/L) | 63.6(53.3–75) | 68.5(59-81.1) | 0.001 | ||
Sodium (mmol/L) | 138.1(135.7-140.6) | 138.3(135.7-141.5) | 0.094 | ||
Potassium (mmol/L) | 3.86(3.55–4.23) | 3.76(3.3–4.43) | 0.113 | ||
Calcium (mmol/L) | 2.12(2.04–2.20) | 2.09(2.00-2.15) | < 0.001 | ||
Total Protein (g/L) | 60.4(55.9–65.1) | 59.5(52.3–62.9) | < 0.001 | ||
Albumin (g/L) | 38.1(34.8-40.35) | 36.2(33.6-40.35) | 0.001 | ||
Globulin (g/L) | 22(19–25) | 22(18–24) | < 0.001 | ||
TBiL (umol/L) | 14.8(10.4–20.7) | 13.9(10.1–19.1) | 0.28 | ||
AST (U/L) | 35(21–63) | 38.5(23–68) | 0.101 | ||
ALT (U/L) | 43(27–71) | 54(33.5–79.5) | < 0.001 | ||
APTT (s) | 34.5(31.9–38.3) | 36.0(32.8–40.1) | < 0.001 | ||
PT (s) | 13.8(13.5–14.5) | 14.6(13.7–15.8) | < 0.001 | ||
INR | 1.07(1.01–1.13) | 1.15(1.08–1.26) | < 0.001 | ||
Fib (g/L) | 3.01(2.13–4.59) | 2.36(1.69–3.99) | < 0.001 | ||
Intraoperative interventions | |||||
Type of Anaesthesia | General anaesthesia | 809(90.1%) | 294(96.1%) | 0.001 | |
Sodium Bicarbonate | 37(4.1%) | 83(27.1%) | < 0.001 | ||
Vasoperssor (intraoperative) | 447(49.8%) | 261(85.3%) | < 0.001 | ||
Tourniquet | 49(5.5%) | 12(3.9%) | 0.29 | ||
Warming Equipment | 309(34.4%) | 118(38.6%) | 0.19 | ||
Haemostatic drugs(intraoperative) | 5(0.6%) | 9(2.9%) | 0.002 | ||
Operation Time (min) | 160(115–225) | 180.5(135.5–255) | 0.001 | ||
Blood Loss (mL) | 300(100–500) | 500(200–1200) | < 0.001 | ||
Autologous Blood (mL) | 0.0(0.0–0.0) | 0.0(0.0-250) | < 0.001 | ||
Plasma (mL) | 0(0.0–0.0) | 0(0.0-400) | < 0.001 | ||
Crystalloid (mL) | 1100(900–1600) | 1500(1000–2200) | < 0.001 | ||
Colloid (mL) | 500(500–1000) | 1000(1000–1500) | < 0.001 | ||
Urine (mL) | 300(200–500) | 325(200–600) | 0.063 | ||
Temperature(postoperative) [℃] | 36.6(36.3–36.9) | 36.5(36.0-36.8) | < 0.001 |